Albuterol (Salbutamol) Found In Paris Hilton Purse During Arrest – Health Related Infos (blog)


msnbc.com

Albuterol (Salbutamol) Found In Paris Hilton Purse During Arrest
Health Related Infos (blog)
It is often used to treat acute asthma, and also provides protection against exercise-induced asthma. While the substance is not used as any sort of
Paris Hilton charged with felony, denies purse was hers, according to policeEntertainment Weekly
What's Albuterol? A Prescription Medication Found with Paris HiltonHULIQ
Albuterol Found Along with Cocaine on Paris HiltonThe News of Today
Execte News –New York Daily News –The Associated Press
all 3,203 news articles »

View full post on asthma – Google News

Man’s Best Friend? Not During Hay Fever Season – Newswise (press release)


News 8 Austin

Man's Best Friend? Not During Hay Fever Season
Newswise (press release)
To learn more about allergies and asthma, take a free relief self-test or find an allergist near you visit www.AllergyAndAsthmaRelief.org.
Allergies plaguing people in the Chippewa ValleyWEAU-TV 13
Allergy season in full bloom in Northeast WisconsinFox11online.com
Mother Nature not going easy on ragweed sufferersNews 8 Austin

all 6 news articles »

View full post on asthma – Google News

NIH-Funded Study Finds Early HAART during TB Treatment Boosts Survival Rate in People Co-Infected with HIV and TB

A clinical trial in Cambodia has found it possible to prolong the survival of untreated HIV-infected adults with very weak immune systems and newly diagnosed tuberculosis (TB) by starting anti-HIV therapy two weeks after beginning TB treatment, rather than waiting eight weeks, as has been standard. This finding by scientists co-funded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, and the French National Agency for Research on AIDS and Viral Hepatitis, brings physicians closer to optimizing the treatment of severely immunosuppressed individuals with HIV-TB co-infection. The findings were presented today at the XVIII International AIDS Conference in Vienna by principal investigators Francois-Xavier Blanc, M.D., Anne E. Goldfeld, M.D., and Sok Thim, M.D.

View full post on National Institutes of Health (NIH) News Releases